Joong Myung Cho – Chairman & CEO, CrystalGenomics, South Korea
Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery…
Address: 735, Yeoksam-dong, Gangnam-gu, Seoul,Republic of Korea
Tel: (02) 527.5500
Web: http://www.sanofi.co.kr/l/kr/ko/index.jsp
Today Sanofi-aventis is the number one multinational pharmaceutical company in Republic of Korea, a leading global pharmaceutical company, contributes to improving life by providing a broad offering of medicines, vaccines, and integrated healthcare solutions adapted to local needs and means. Republic of Korea has already become one of the most important countries in terms of clinical trials for Sanofi-Aventis worldwide becoming the company’s fifth largest recipient of clinical trial investments after the United States, France, Germany and the United Kingdom.
Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery…
Young-Shik Cho, chairman of SD Biosensor, recounts his journey leading diagnostics companies and expanding their…
The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome…
Dr Jeong-Sun Seo, chairman of Macrogen & president of the Korea Biotechnology Industry Organization (KoreaBIO),…
Gencurix was the first Asian company to develop a prognostic diagnostic test for breast cancer. Its CEO, Dr Sangrae…
Yeul-Hong Kim, Director of K-MASTER details the project’s success in creating a shared database of genomic data…
Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the…
Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in…
Genome & Company, with a market cap of USD 280 million, is the highest valued microbiome company worldwide. Dr…
After failing to attain reimbursement for its Amyotrophic Lateral Sclerosis (ALS) treatment NEURONATA-R® in Korea,…
Kyung Suk Kim, CEO of Corestem, the first company to receive approval for a stem cell therapy for Amyotrophic…
With over 30 years of experience in public office working in public health and pharmaceutical policy, food and drug…